|
Volumn 8, Issue 11, 1998, Pages 1381-1386
|
New tetrahydronaphthalene derivatives as combined thromboxane receptor antagonists and thromboxane synthase inhibitors
|
Author keywords
[No Author keywords available]
|
Indexed keywords
15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID;
PROSTAGLANDIN H2;
TETRALIN DERIVATIVE;
THROMBOXANE A2;
THROMBOXANE RECEPTOR BLOCKING AGENT;
THROMBOXANE SYNTHASE INHIBITOR;
ANIMAL EXPERIMENT;
ARTICLE;
DRUG MECHANISM;
DRUG STRUCTURE;
DRUG SYNTHESIS;
ENZYME ACTIVITY;
HUMAN;
HUMAN TISSUE;
MOLECULAR MODEL;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PLASMA PROTEIN BINDING;
RABBIT;
RAT;
RECEPTOR BLOCKING;
SAPHENOUS VEIN;
STEREOCHEMISTRY;
STRUCTURE ACTIVITY RELATION;
THROMBOCYTE AGGREGATION INHIBITION;
15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID;
ANIMALS;
ENZYME INHIBITORS;
GUINEA PIGS;
HUMANS;
MUSCLE CONTRACTION;
MUSCLE, SMOOTH, VASCULAR;
PLATELET AGGREGATION INHIBITORS;
PRESSURE;
RABBITS;
RECEPTORS, THROMBOXANE;
STRUCTURE-ACTIVITY RELATIONSHIP;
SULFONAMIDES;
TETRAHYDRONAPHTHALENES;
THROMBOXANE-A SYNTHASE;
TRACHEA;
|
EID: 0032474559
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0960-894X(98)00221-2 Document Type: Article |
Times cited : (22)
|
References (15)
|